March 02, 2015 8:07 PM ET

Biotechnology

Company Overview of Invitae Corporation

Company Overview

Invitae Corporation, a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare. It processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company provides a single diagnostic service comprising approximately 200 genes for various genetic disorders associated primarily with cancer, but also covering cardiology, hematology, neurology, and pediatrics. It also offers solutions that enable sharing...

458 Brannan Street

San Francisco, CA 94107

United States

Founded in 2010

144 Employees

Phone:

415-374-7782

Key Executives for Invitae Corporation

Chairman, Chief Executive Officer and Member of Strategy Team
Age: 56
Total Annual Compensation: $203.7K
Co-Founder, President, Chief Operating Officer, Member of Strategy Team and Director
Age: 40
Total Annual Compensation: $281.9K
Chief Commercial Officer and Member of Strategy Team
Age: 42
Total Annual Compensation: $286.6K
Compensation as of Fiscal Year 2014.

Invitae Corporation Key Developments

InVitae Corporation Seeks Acquisitions

InVitae Corporation has filed for an IPO in the amount of $86.25 million. They may use the net proceeds from this offering to license, acquire or invest in complementary business, technologies, products or assets.

InVitae Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 05:00 PM

InVitae Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 05:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Randy Scott, Chairman and CEO.

Invitae Corporation and Nanopharmacia Announce Partnership to Make Reliable, Fast and Affordable Hereditary Cancer Genetic Testing Broadly Available in Mexico

Invitae Corporation and Nanopharmacia announced an exclusive partnership to make Invitae's genetic tests for the management of hereditary cancers broadly available throughout Mexico. In addition, the partnership includes access on a non-exclusive basis in Costa Rica and Panama. Nanopharmacia will offer Invitae's hereditary cancer panels and BRCA1/BRCA2 offering to a wide network of onco-geneticists and medical and surgical oncologists. Invitae's oncology offering includes: Single gene BRCA1 and BRCA2, including full gene sequencing and deletion/duplication analysis; High-risk hereditary breast cancer panel (6 genes); Women's hereditary cancer panel (18 genes associated with hereditary breast, ovarian and endometrial cancer); Hereditary cancer syndromes panel (29 genes); Hereditary Pancreatic Cancer Panel (17 genes); Additional hereditary cancer panels are available, including testing for Lynch Syndrome and colon cancers. The partnership includes access for advanced next generation genetic testing in Mexico through a network of approximately 800 oncology professionals in Mexico, as well as in Costa Rica and Panama.

Similar Private Companies By Industry

Company Name Region
Callisto Pharmaceuticals, Inc. United States
Grifols Biologicals, Inc. United States
Lehigh Nanotech, LLC United States
aTyr Pharma Inc. United States
Americare Health Scan, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 13, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Invitae Corporation, please visit invitae.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.